Galeazzi R L, Gugger M, Weidmann P
Kidney Int. 1979 Jun;15(6):661-8. doi: 10.1038/ki.1979.86.
Cardiac and renal effects (measured as the reduction in exercise-induced tachycardia and PRA, respectively) and circulating drug concentrations after acute beta blockade with intravenous pindolol were compared between seven normal volunteers and six patients with terminal renal failure. Kinetic parameters were similar in both groups (total body clearance, 450 mg/min), indicating enhanced extrarenal elimination in patients. For any given drug concentration, however, the uremic patients responded to beta blockade with a greater decrease in pulse rate than did normal volunteers (P less than 0.001). Moreover, in the same group, the decrease of PRA was more marked (from 13.3 to 5.7 vs. 3.3 to 1.9 ng/ml/hr) and lasted longer (8 hours and more vs. 2 hours). Plasma aldosterone remained unchanged. These data reveal an increased dependency of both heart rate and renin release on beta adrenergic-mediated mechanisms in uremic man. They also show that kinetic findings in normal subjects cannot always be extrapolated to predict kinetic behavior in disease, and that similar kinetics do not imply similar effectiveness.
比较了7名正常志愿者和6名终末期肾衰竭患者静脉注射吲哚洛尔进行急性β受体阻滞剂治疗后的心脏和肾脏效应(分别以运动诱发的心动过速和血浆肾素活性的降低来衡量)以及循环药物浓度。两组的动力学参数相似(全身清除率,450mg/min),表明患者的肾外清除增强。然而,对于任何给定的药物浓度,尿毒症患者对β受体阻滞剂的反应是心率下降幅度大于正常志愿者(P<0.001)。此外,在同一组中,血浆肾素活性的下降更为明显(从13.3降至5.7与从3.3降至1.9ng/ml/hr)且持续时间更长(8小时及以上与2小时)。血浆醛固酮保持不变。这些数据揭示了尿毒症患者心率和肾素释放对β肾上腺素能介导机制的依赖性增加。它们还表明,正常受试者的动力学结果并不总是能够外推以预测疾病中的动力学行为,并且相似的动力学并不意味着相似的有效性。